NUS Extraordinary Items vs Selling And Marketing Expenses Analysis
NUS Stock | USD 12.28 0.03 0.24% |
Nu Skin financial indicator trend analysis is infinitely more than just investigating Nu Skin Enterprises recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Nu Skin Enterprises is a good investment. Please check the relationship between Nu Skin Extraordinary Items and its Selling And Marketing Expenses accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nu Skin Enterprises. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment.
Extraordinary Items vs Selling And Marketing Expenses
Extraordinary Items vs Selling And Marketing Expenses Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Nu Skin Enterprises Extraordinary Items account and Selling And Marketing Expenses. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Nu Skin's Extraordinary Items and Selling And Marketing Expenses is -0.25. Overlapping area represents the amount of variation of Extraordinary Items that can explain the historical movement of Selling And Marketing Expenses in the same time period over historical financial statements of Nu Skin Enterprises, assuming nothing else is changed. The correlation between historical values of Nu Skin's Extraordinary Items and Selling And Marketing Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Extraordinary Items of Nu Skin Enterprises are associated (or correlated) with its Selling And Marketing Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Selling And Marketing Expenses has no effect on the direction of Extraordinary Items i.e., Nu Skin's Extraordinary Items and Selling And Marketing Expenses go up and down completely randomly.
Correlation Coefficient | -0.25 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Extraordinary Items
Selling And Marketing Expenses
Most indicators from Nu Skin's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Nu Skin Enterprises current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nu Skin Enterprises. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment. At this time, Nu Skin's Selling General Administrative is comparatively stable compared to the past year. Sales General And Administrative To Revenue is likely to gain to 0.37 in 2024, despite the fact that Tax Provision is likely to grow to (16.1 M).
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 2.0B | 1.6B | 1.4B | 1.4B | Total Revenue | 2.7B | 2.2B | 2.0B | 1.8B |
Nu Skin fundamental ratios Correlations
Click cells to compare fundamentals
Nu Skin Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Nu Skin fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 1.8B | 2.0B | 1.9B | 1.8B | 1.8B | 1.2B | |
Other Current Liab | 270.1M | 366.6M | 339.1M | 253.2M | 216.1M | 214.0M | |
Total Current Liabilities | 356.8M | 542.9M | 529.7M | 359.2M | 328.9M | 305.0M | |
Total Stockholder Equity | 875.3M | 894.3M | 912.8M | 897.3M | 822.0M | 572.2M | |
Property Plant And Equipment Net | 597.9M | 653.5M | 574.6M | 543.5M | 523.1M | 263.7M | |
Net Debt | 132.0M | 97.7M | 125.4M | 214.3M | 351.3M | 368.8M | |
Retained Earnings | 1.7B | 1.8B | 1.9B | 1.9B | 1.9B | 1.0B | |
Accounts Payable | 39.0M | 66.2M | 50.0M | 54.0M | 43.5M | 34.4M | |
Cash | 335.6M | 402.7M | 339.6M | 264.7M | 256.1M | 248.8M | |
Non Current Assets Total | 1.0B | 1.1B | 1.0B | 1.1B | 1.1B | 607.7M | |
Non Currrent Assets Other | 154.0M | 50.6M | 113.1M | 115.2M | 110.0M | 104.5M | |
Cash And Short Term Investments | 344.0M | 423.9M | 354.8M | 278.5M | 267.8M | 256.4M | |
Net Receivables | 50.4M | 63.4M | 41.3M | 47.4M | 72.9M | 76.5M | |
Common Stock Shares Outstanding | 55.9M | 52.8M | 51.4M | 50.5M | 49.9M | 54.3M | |
Liabilities And Stockholders Equity | 1.8B | 2.0B | 1.9B | 1.8B | 1.8B | 1.2B | |
Non Current Liabilities Total | 537.0M | 519.9M | 464.0M | 564.4M | 655.6M | 688.4M | |
Inventory | 275.9M | 314.4M | 399.9M | 346.2M | 280.0M | 187.9M | |
Other Current Assets | 69.9M | 14.7M | 76.9M | 87.8M | 71.0M | 65.8M | |
Other Stockholder Equity | (767.3M) | (881.8M) | (925.2M) | (955.8M) | (948.6M) | (901.2M) | |
Total Liab | 893.7M | 1.1B | 993.7M | 923.7M | 984.5M | 586.6M | |
Total Current Assets | 740.2M | 903.2M | 873.0M | 759.9M | 691.6M | 551.1M | |
Short Long Term Debt Total | 467.7M | 500.4M | 465.0M | 479.0M | 607.3M | 637.7M | |
Short Term Debt | 27.5M | 75.0M | 107.5M | 25M | 48.9M | 51.8M | |
Property Plant And Equipment Gross | 597.9M | 653.5M | 453.7M | 444.8M | 897.6M | 942.5M | |
Accumulated Other Comprehensive Income | (85.3M) | (64.8M) | (73.9M) | (86.5M) | (100.0M) | (105.0M) | |
Intangible Assets | 80.3M | 89.5M | 77.0M | 66.7M | 105.3M | 84.0M | |
Other Liab | 96.8M | 102.3M | 106.5M | 98.3M | 113.0M | 72.4M | |
Other Assets | 154.0M | 293.2M | 175.5M | 244.4M | 281.1M | 152.1M | |
Long Term Debt | 334.5M | 305.4M | 268.8M | 377.5M | 478.0M | 501.9M | |
Property Plant Equipment | 453.6M | 468.2M | 453.7M | 444.8M | 511.5M | 275.1M | |
Current Deferred Revenue | 20.2M | 35.1M | 33.1M | 27.1M | 20.4M | 17.9M | |
Short Term Investments | 8.4M | 21.2M | 15.2M | 13.8M | 11.8M | 13.7M | |
Treasury Stock | (1.3B) | (1.3B) | (1.5B) | (1.5B) | (1.4B) | (1.3B) | |
Net Tangible Assets | 875.3M | 894.3M | 912.8M | 897.3M | 1.0B | 829.4M | |
Retained Earnings Total Equity | 1.7B | 1.8B | 1.9B | 1.9B | 2.2B | 1.6B | |
Long Term Debt Total | 334.5M | 313.1M | 274.1M | 389.6M | 448.0M | 321.7M | |
Capital Surpluse | 557.5M | 579.8M | 601.7M | 613.3M | 705.3M | 500.0M | |
Non Current Liabilities Other | 105.7M | 112.3M | 88.8M | 76.5M | 9.0M | 8.5M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nu Skin Enterprises. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for NUS Stock analysis
When running Nu Skin's price analysis, check to measure Nu Skin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nu Skin is operating at the current time. Most of Nu Skin's value examination focuses on studying past and present price action to predict the probability of Nu Skin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nu Skin's price. Additionally, you may evaluate how the addition of Nu Skin to your portfolios can decrease your overall portfolio volatility.
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |
Is Nu Skin's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nu Skin. If investors know NUS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nu Skin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.88) | Dividend Share 1.56 | Earnings Share 0.17 | Revenue Per Share 39.612 | Quarterly Revenue Growth (0.07) |
The market value of Nu Skin Enterprises is measured differently than its book value, which is the value of NUS that is recorded on the company's balance sheet. Investors also form their own opinion of Nu Skin's value that differs from its market value or its book value, called intrinsic value, which is Nu Skin's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nu Skin's market value can be influenced by many factors that don't directly affect Nu Skin's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nu Skin's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nu Skin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nu Skin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.